CTOs on the Move

Diagnocure

www.diagnocure.com

 
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.diagnocure.com
  • 4535 Wilfrid-Hamel Blvd Suite 250
    Quebec, QC CAN G1P 2J7
  • Phone: 418.527.6100

Executives

Name Title Contact Details

Similar Companies

BioStat Solutions

BioStat Solutions is a Mount Airy, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthSpace Integrated Solutions

HealthSpace Integrated Solutions is a Glen Allen, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GeneSolve

GeneSolve is the world’s first dedicated body chemistry company, with offices in the San Francisco Bay Area and Dallas, Texas.   GeneSolve doctors utilize extensive laboratory tests and genetic analysis to provide personalized preventative health care programs to individual patients, as well as to groups through corporate wellness programs.

Landmark Health Solutions Company

Landmark Health Solutions Company is a Haverhill, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.